The aim of this study was to investigate the reproducibility of intravascular optical coherence tomography (IVOCT) assessments, including a comparison to intravascular ultrasound (IVUS). Intra-observer and inter-observer variabilities of IVOCT have been previously described, whereas inter-institute reliability in multiple laboratories has never been systematically studied.
Introduction
Intravascular ultrasound (IVUS) and intravascular optical coherence tomography (IVOCT) are widely available for evaluating highresolution images of the coronary artery in vivo. Consensus document guidelines have been published for both techniques in order to harmonize their use and analysis. 1 -4 These two techniques are increasingly used for the assessment of the natural history of † A.M. shared senior author.
atherosclerosis, vascular remodelling, and pharmacological and percutaneous interventions. 5 -6 In a core laboratory setting, the interand intra-observer reproducibility for qualitative and quantitative measurements with both techniques has been previously established in many studies. 7 -11 Although one study underlines the necessity to centrally analyse IVUS data obtained in multi-centre studies, 12 to the best of our knowledge, the evaluation of interinstitute reliability for IVOCT is currently lacking. Indeed, awareness of inter-institute differences may be particularly important in multicentre pharmacological or percutaneous intervention trials. Accordingly, the purpose of this study was to investigate further inter-and intra-observer reproducibility, the inter-institute variability for IVOCT quantitative and qualitative measurements vs. IVUS measurements using published consensus document definitions.
Methods

Study population
Forty-two non-consecutive patients scheduled for elective percutaneous coronary intervention (PCI) were enrolled in two centres (Columbia University Medical Center, New York, NY, USA and Lahey Clinic Medical Center, Burlington, MA, USA). MGH, Columbia and Lahey Institutional Review Boards approved the study protocol. Patients with acute coronary syndrome, haemodynamic instability, renal insufficiency (glomerular filtration rate ,50 mL/min), allergy to X-ray contrast, unprotected left main coronary artery disease, venous bypass graft lesions, chronic total occlusions, last remaining vessel, or extremely tortuous vessels were excluded. Patients underwent the following procedures in the catheterization laboratory: coronary angiography, PCI of the culprit lesion, and intravascular imaging in random order: IVOCT imaging and IVUS imaging. About 74 coronary arteries (left anterior descending artery, n ¼ 28; left circumflex artery, n ¼ 23; right coronary artery, n ¼ 23) imaged from these 42 patients were studied. Ninety-six pullbacks on both native (primarily, n ¼ 27) and stented coronary artery segments (pre-PCI, n ¼ 26; post-PCI, n ¼ 43) were included. To assess the inter-observer, intra-observer, and inter-institute variabilities of IVOCT quantitative and qualitative measurements vs. IVUS measurements, randomized matched data sets of 100 IVOCT and 100 IVUS intracoronary images were analyzed by 4 independent observers from 2 different laboratories (E.G. and M.K. for the Tearney laboratory, Massachusetts General Hospital, Boston, MA, USA; T.S. and L.W. for the Columbia University Medical Center, New York, NY, USA) who were blinded to other data ( Table 1) . These four observers had worked for at least 1 year as intravascular imaging researchers and were certified by their respective laboratories by completion of a common training programme.
IVUS acquisition
IVUS imaging was performed after intracoronary administration of nitrates (0.1 -0.2 mg) using commercially available mechanical (iLab TM with 40 MHz Atlantis SR Pro catheters, Boston Scientific, Fremont, CA, USA) or phased-array transducer systems (s5 TM with 20 MHz Eagle Eye Gold catheters, Volcano Therapeutics, Rancho Cordova, CA, USA), as described elsewhere in conventional manner, using an automated pullback device operating at 0.5 mm/s. 13 
IVOCT acquisitions
IVOCT imaging was performed with non-commercial frequency domain optical coherence tomography (FD-OCT) systems (Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA), also known as optical frequency domain imaging (OFDI) systems, that operate and perform identically to commercial IVOCT systems, as described previously. 14, 15 This system used a wavelength-swept laser (center wavelength of 1310 nm) as a light source. The FD-OCT imaging catheter had a short monorail design with a catheter profile of 2.4 Fr, compatible with 6 F guiding catheters. The OCT acquisition technique was in line with recent expert review documents. 3 During the flushing process, motorized pullback FD-OCT imaging was performed at a rate of 20 mm/s.
Matched IVUS-IVOCT image sets
The matched IVUS-IVOCT image sets were made by two independent interventional cardiologists (A.M. or A.T.) who have 10 years of experience in intravascular imaging. They generated Tiff stack files from original IVUS and OCT data. Complex geometries such as side-branch take-off/ bifurcation carina were included. Images were preliminarily evaluated for diagnostic quality. Typical IVUS artefacts (i.e. non-uniform rotational distortion, air bubble, and geometric distortion due to the off-centred position of the IVUS probe in the artery) were excluded. Typical IVOCT artefacts (i.e. movement artefacts, flush defect artefacts, and fibre decentration and non-parallelism artefacts) were also excluded. IVUS and OCT images that were deemed to be of diagnostic quality were then co-registered by pullback distance and confirmed by using anatomical landmarks and following these successive steps: (i) the absolute landmarks were the left anterior descending coronary artery/left circumflex coronary artery bifurcation for the left coronary artery system or the atrioventricular node coronary artery/posterior descending coronary artery bifurcation for the right coronary artery system; (ii) additional anatomical landmarks, i.e. side branch or perivascular structure such as vein, and muscle were systematically used; (iii) morphological features in the crosssectional image, including calcification shape, prominent vasa vasorum, and lumen morphology, were also used to confirm registration precision; (iv) stent features including post-stent or old stent cases permitted us to obtain corresponding images of IVUS and IVOCT; and (v) known pullback speed was integrated when pullbacks were considered quite stable (i. and confirmed the same length (,10% difference) between IVUS and IVOCT. In this database, sets of 100 IVUS -IVOCT matched images were generated using web-based randomization software.
IVUS data analysis
IVUS measurements, both geometric and compositional analyses, were made on a standalone computer workstation using ImageJ software. 16 All quantitative and qualitative data were evaluated following published consensus document definitions. 1, 2 The lumen and vessel borders were traced manually for each image ( Figure 1) . To evaluate the intra-observer variability, one observer of the Columbia University Medical Center repeated the analysis of another set 1 month later. The following quantitative data were measured: lumen cross-sectional area (CSA), minimum and maximum luminal diameters, stent CSA, minimum and maximum stent diameters, external elastic membrane (EEM) area when identified and/or present under the lesion [excluding cross-sectional images that contain artefacts that obscure a significant portion (.908)], atheroma CSA (defined by the EEM CSA minus lumen CSA), plaque burden [calculated as (atheroma CSA/EEM CSA) × 100 (%)], minimum and maximum atheroma thicknesses, atheroma eccentricity index [calculated as (maximum atheroma thickness -minimum atheroma thickness)/maximum atheroma thickness], the total arc of attenuation, and the total arc of calcium. The total arc of attenuation equals the sum of different arcs of attenuation in the same cross-section. The total arc of calcium equals the sum of different arcs of calcium in the same cross-section. According to consensus document definitions, 1 plaque composition was also characterized in one of the following categories: hypoechoic, hyperechoic/isoechoic, calcified, or mixed. Echo-attenuated plaque was also identified by the absence of the ultrasound signal behind plaque that was either hypoechoic or isoechoic, but contained no bright calcium. Plaque rupture, thrombus, plaque protrusion, and incomplete stent apposition and dissection were also assessed.
IVOCT data analysis
Anonymized data were analysed on a standalone computer workstation using ImageJ software 16 ( Figure 2 ). All quantitative and qualitative data were evaluated following the published consensus document definitions. 3, 4 To evaluate the intra-observer variability, one observer of the Tearney laboratory repeated the analysis of another set 1 month later. The following quantitative data were measured: lumen CSA, minimum and maximum luminal diameters, stent CSA, minimum and maximum stent diameters, EEM area when identified and/or present under the lesion, atheroma CSA (defined by the EEM CSA minus lumen CSA), plaque burden [calculated as (atheroma CSA/EEM CSA) × 100 (%)], minimum and maximum atheroma thicknesses, atheroma or plaque eccentricity index, and internal elastic membrane (IEM) when identified and/or present under the lesion. The same lumen measurements as for EEM have been made for the IEM. All these measurements were obtained, if EEM and/or IEM was clearly identified in the IVOCT image (excluding EEM and/or IEM delineation when the image contains a significant obscure part on more than 908 of its circumference). According to consensus document definitions, plaque composition was also characterized in one of the following categories: fibroatheroma, fibrous plaque, and fibrocalcific plaque. The cut-off minimal cap thickness used to define the thin-capped fibroatheroma was 65 mm. The maximum lipid arc, the fibrous cap thickness (mean of three successive measurements), and the maximum calcium arcs were also measured. Plaque rupture, thrombus, prolapse, stent malapposition, dissection, macrophages within plaque, cholesterol crystals, and intimal vessels were also identified. 3 
Statistical analysis
Continuous data are expressed as mean + standard deviation or median (interquartile range) when appropriate. Intra-observer and inter-institute variabilities for IVUS and IVOCT quantitative data were determined as mean (relative) difference (bias) and standard deviations, Figure 1 Example of IVUS measurements. Lumen and EEM areas are delineated. The minimum and maximum lumen diameters are illustrated using a double-headed arrow (open and solid arrowheads, respectively). Furthermore, the minimum and maximum atheroma thicknesses are illustrated using doubleheaded arrows (white for minimum and black for maximum). Figure 1 . Lumen and EEM areas are traced. The minimum and maximum lumen diameters are illustrated using a double-headed arrow (open and solid arrowheads, respectively). Furthermore, the minimum and maximum atheroma thicknesses are illustrated using doubleheaded arrows (white for minimum and black for maximum).
according to the methods of Bland and Altman. For each image, the magnitude of the difference observed between the two laboratories was computed as the absolute value for lumen CSA, minimum and maximum luminal diameters, stent CSA, minimum and maximum stent diameters, EEM area when identified and/or present under the lesion, atheroma CSA, plaque burden, minimum and maximum atheroma thicknesses, and atheroma or plaque eccentricity index. (Figure 3 and see Supplementary data online, Table S1 ). Likewise, the mean (standard deviation) differences were negligible for stent CSA and minimum and maximum stent diameters (0.04 + 0.23 mm 2 and 0.004 + 0.13 and 0.03 + 0.11 mm, respectively). Intra-observer variability was also low for EEM area, atheroma CSA, plaque burden, minimum atheroma Figure 3 Intra-observer variability of lumen CSA, stent CSA, and atheroma CSA for IVUS and IVOCT measurements. 
Intra-observer variability for IVOCT measurements
Intra-observer variability was very low for lumen CSA and minimum and maximum luminal diameters (0.04 + 0.19 mm 2 , 0.03 + 0.11 mm, and 0.04 + 0.13 mm, respectively) ( Figure 3 and see Supplementary data online, Table S2 ). Likewise, the mean differences (standard deviation) were negligible for stent CSA and minimum and maximum stent diameters (0.05 + 0.26 mm 2 and 0.02 + 0.09 and 0.03 + 0.13 mm, respectively). Intra-observer variability was also low for EEM area, atheroma CSA, plaque burden, minimum atheroma thickness, maximum atheroma thickness, and atheroma eccentricity index (0.13 + 0.39 mm Bland and Altman showed a good agreement for the lipid and calcium arc measurements (1.8 + 6.88 and 22.4 + 9.28, respectively). Furthermore, the mean difference (standard deviation) for the fibrous cap thickness was 23.6 + 11.6 mm. Regarding qualitative data, the kappa values for intra-observer agreement on fibroatheroma, fibrous, and fibrocalcific plaque characterization were 0.83, 0.84, and 0.86, respectively.
Inter-observer variability for IVUS measurements
The ICC was 0.98 [95% confidence interval (CI): 0.97-0.99] for lumen CSA, 0.94 (95% CI: 0.92-0.96) for minimum lumen diameter, and 0.95 (95% CI: 0.90-0.98) for maximum lumen diameter (see Supplementary data online, Table S3 
Inter-observer variability for IVOCT measurements
k ¼ 0.81), thrombus (k ¼ 0.88), prolapse (k ¼ 1.0), stent malapposi- tion (k ¼ 1.0), dissection (k ¼ 0.91),
Inter-institute variability for IVUS and IVOCT measurements
Inter-institute mean differences and standard deviations for quantitative IVUS and IVOCT geometrical measurements are shown in Table 2 and Figure 4 . The magnitudes of measurement differences between the two institutes are compared in Table 3 . EEM CSA Figure 4 Inter-institute variability of lumen CSA, stent CSA, and atheroma CSA for IVUS and IVOCT measurements. Middle line: mean difference; top and bottom dotted lines: mean +1.96 SD and mean 21.96 SD, respectively.
was measured by both institute observers in 90% of the IVUS images and in 40% of the IVOCT corresponding images. In the 40 IVOCT images, in which EEM CSA was defined by both institutes' observers, EEM CSA could also be determined in all corresponding IVUS images. The magnitude of inter-institute measurement differences for IVOCT was statistically significantly less than that of interinstitute measurement differences for IVUS in the following assessments: lumen CSA, maximum and minimum lumen diameters, stent CSA, and maximum and minimum stent diameters. When IVOCT measurements were available (i.e. EEM was identified), a similar trend was observed for EEM CSA, atheroma CSA, plaque burden, and minimum and maximum atheroma thicknesses ( Table 3) 
Discussion
In this study, the main finding is that the inter-institute variability of measurements for IVOCT is statistically significantly less than that of measurements for IVUS in the following assessments: lumen CSA, maximum and minimum lumen diameters, stent CSA, and maximum and minimum stent diameters. Furthermore, intra-and interobserver variability results for both techniques in this study were nearly similar to other studies previously published. In our study, the inter-institute variability of geometrical measurements for IVOCT is statistically significantly less than that for IVUS. The first explanation is that the spatial resolution of IVOCT is greater than that of IVUS. Thus, the axial resolution ranges from 10 to 20 mm, compared with 80 -100 mm for IVUS. Furthermore, the lateral resolution in IVOCT catheters is typically 30 -50 mm when compared with 150 -250 mm for IVUS. 6 Another possible reason for this difference is the superior ability of OCT to visualize the lumen -intima interface compared with IVUS, therefore allowing OCT to visualize the true lumen dimensions, which IVUS can sometimes overestimate. 18 This finding is consistent with that of Magnus In the 40 OFDI images, in which EEM CSA was measured by both institute observers, EEM CSA could also be determined in all corresponding IVUS images.
IVOCT compared with IVUS, which is a bias in the results comparison. The reason that the EEM is more frequently identified in IVUS is that IVUS signal penetration ( 5 mm) is deeper than IVOCT penetration ( 2 mm) and IVOCT light is significantly attenuated by lipid. Consequently, although IVUS measurements are probably less consistent than IVOCT measurements, IVUS still appears to be the best technique for evaluating plaque burden and vascular remodelling, regardless of the composition of the plaque. Concerning plaque composition, the inter-institute agreement for both techniques yielded a substantial concordance. As demonstrated in this study, assessments by analysts from two different centres with the same training programme may result in statistically significant minor differences for plaque composition. In trials in which both technologies are being increasingly used and in which minor changes in plaque composition are expected, 5 awareness of the inter-institute difference may be important in the design of a multi-centre study. Using published consensus document definitions, our study evaluated intra-and inter-observer variabilities of both techniques regarding a wide and nearly complete range of quantitative and qualitative data. Previous studies were generally more focused on a specific analysis. Inter-observer IVUS assessments of plaque composition were highly correlated, except possibly for mixed plaque (k ¼ 0.70). Likewise, Palmer et al. 9 showed a high level of agreement except for heterogeneous/mixed plaque (k ¼ 0.78). We suppose that part of this variability may be due to the definition of a mixed plaque. Inter-observer IVOCT reproducibility yielded a very good concordance for all geometry measurements, except for the fibrous cap thickness (ICC ¼ 0.48). Similarly, Kim et al. 20 observed equivalent ICC values, emphasizing that it remains challenging to detect the inner border of the lipid pool within the plaque for cap measurement. Finally, in our study, the reliability for macrophages, cholesterol crystals, and intimal vessels identification was also acceptable. To the best of our knowledge, this finding has never been reported.
Limitations
Our study included a small number of images (n ¼ 100) per set. However, the analysis was complete, including a wide range of quantitative and qualitative data using published consensus document definitions. To generate the sets, images with poor quality were excluded, which is a bias of selection. The matching process used in this study may have some imperfections. The adoption of dedicated software can overcome this limitation, such as carpet view analysis of IVOCT images that has been recently described to enable a matching comparison of the same stent portion during serial time points. 21 This study was conducted in two highly experienced centres in intravascular imaging in the USA. The results of this study may not be applicable elsewhere. Analyses were performed offline on selected images of coronary segments from patients with stable angina. Thus, our findings cannot be extrapolated to inter-institute studies in an online setting or in patients with acute coronary syndromes. Our noncommercial IVOCT system is similar to the Terumo FD-OCT imaging system (Lunawave, Terumo, Tokyo, Japan). Finally, parameters such as vessel location, vessel size, plaque burden, calcification, de novo vs. stented lesions, flushing media, and ECG cycle that could affect differences between IVOCT and IVUS assessments were not incorporated in the analysis.
Conclusion
In the measurement of lumen CSA, maximum and minimum lumen diameters, stent CSA, and maximum and minimum stent diameters by analysts from two different laboratories, inter-institute reproducibility of IVOCT was found to be more consistent than that of IVUS.
Inter-institute agreement is substantial using both technologies for plaque composition. These findings may have important implications for the design of future studies that pool intravascular imaging parameters evaluated and measured by multiple institutions.
Supplementary data
Supplementary data are available at European Heart JournalCardiovascular Imaging online.
